{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:59:13Z","timestamp":1781812753976,"version":"3.54.5"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the efficacy of transcervical intralesional vasopressin injection to submucous myoma in hysteroscopic myomectomy from 2011 to 2014.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was a prospective, randomized, double-blind study in a single center. Forty premenopausal women with symptomatic submucous myoma requiring hysteroscopic myomectomy were randomized to transcervical intralesional vasopressin injection or placebo in a 4:4 ratio. The primary outcome was operative time. Secondary outcomes including fluid volumes, blood loss, and visual clarity were compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The median duration for myomectomy was 19.9 minutes (range 3.1\u201354.2 minutes) in the vasopressin group compared with 29.0 minutes (range 8.0\u201360.9 minutes) in the placebo group, a nonsignificant difference (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.14). There were significant reductions in the median volume of fluid used (4,200 mL [range 1,300\u201321,000 mL] compared with 9,800 mL (range 1,500\u201323,000 mL;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.004) and fluid intravasation (0 mL [range 0\u20133,100] compared with 300 mL [range \u2013150\u20133,150 mL;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.029) in the vasopressin group. The median intraoperative blood loss was reduced (5 mL [range 1\u201350 mL] compared with 20 mL [range 1\u2013150 mL;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.002). The operative surgeon rated that 95% of the vasopressin group had \u201cminimal\u201d bleeding compared with 36.8% in the placebo group. The surgical field (visual analog scale [VAS] 9 [range 2\u201310] compared with 6 [range 2\u201310;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001]; 0=worst visual clarity, 10=best visual clarity) and the effluent fluid (VAS 1 [range 0\u20137] compared with 4 [range 0\u20138;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001]; 0=clear, 10=unclear) were statistically significantly clearer in the vasopressin group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Transcervical intralesional vasopressin injection in hysteroscopic myomectomy did not reduce operative time but did reduce volume of inflow fluid, fluid intravasation, intraoperative blood loss, and improving visual clarity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>Centre for Clinical Research and Biostatistics, http:\/\/www.cct.cuhk.edu.hk\/Registry\/publictriallist.aspx, CUHK_CCT00291.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>I<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000000515","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T08:41:30Z","timestamp":1412671290000},"page":"897-903","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["Transcervical Intralesional Vasopressin Injection Compared With Placebo in Hysteroscopic Myomectomy"],"prefix":"10.1097","volume":"124","author":[{"given":"Alyssa Sze Wai","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Wai","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sik Wing","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu Lan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak Yeung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daljit Singh","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20260528","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.fertnstert.2011.01.147","article-title":"Feasibility of a new system of classification of submucous myomas: a multicenter study.","volume":"95","author":"Lasmar","year":"2011","journal-title":"Fertil Steril"},{"key":"R3-6-20260528","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejogrb.2006.01.014","article-title":". Long-term results of hysteroscopic myomectomy in 235 patients.","volume":"130","author":"Polena","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R5-6-20260528","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/humupd\/dmm041","article-title":". Hysteroscopic myomectomy: a comprehensive review of surgical techniques.","volume":"14","author":"Di Spiezio Sardo","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R6-6-20260528","first-page":"736","article-title":"Transcervical hysteroscopy resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension.","volume":"82","author":"Wamsteker","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R7-6-20260528","first-page":"517","article-title":"Complications of hysteroscopic surgery: predicting patients at risk.","volume":"96","author":"Propst","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R9-6-20260528","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1471-0528.1990.tb01824.x","article-title":"Treatment with GnRH agonists before myomectomy and the risk of short-term fibroid recurrence.","volume":"97","author":"Fedele","year":"1990","journal-title":"Br J Obstet Gynecol"},{"key":"R10-6-20260528","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.0001-6349.2005.00690.x","article-title":"Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women.","volume":"84","author":"Campo","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R11-6-20260528","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejogrb.2014.03.009","article-title":"Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis.","volume":"177","author":"Kamath","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R12-6-20260528","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/deq188","article-title":"The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.","volume":"25","author":"Mavrelos","year":"2010","journal-title":"Hum Reprod"},{"key":"R13-6-20260528","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.fertnstert.2009.05.070","article-title":". GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study.","volume":"94","author":"Muzii","year":"2010","journal-title":"Fertil Steril"},{"key":"R14-6-20260528","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijgo.2007.05.050","article-title":"A systemic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids.","volume":"100","author":"Kongnyuy","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"R15-6-20260528","first-page":"419","article-title":"Effects of vasopressin administration during hysteroscopic surgery.","volume":"39","author":"Corson","year":"1994","journal-title":"J Reprod Med"},{"key":"R16-6-20260528","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0029-7844(96)00282-7","article-title":"The effect of dilute vasopressin solution on blood loss during operative hysteroscopy: a randomized controlled trial.","volume":"88","author":"Phillips","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R17-6-20260528","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1089\/lap.2012.0424","article-title":"Transcervical intralesional vasopressin injection in hysteroscopic myomectomydescription of a new technique.","volume":"23","author":"Wong","year":"2013","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"R18-6-20260528","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0015-0282(16)55790-2","article-title":"Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study.","volume":"59","author":"Perino","year":"1993","journal-title":"Fertil Steril"},{"key":"R19-6-20260528","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart.","volume":"97","author":"Higham","year":"1990","journal-title":"BJOG"},{"key":"R20-6-20260528","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0015-0282(97)00335-X","article-title":"An analysis of fluid loss during transcervical resection of submucous myomas.","volume":"68","author":"Emanuel","year":"1997","journal-title":"Fertil Steril"},{"key":"R21-6-20260528","first-page":"476","article-title":"Vasopressin: if some is good, is more better Obstet G","volume":"113","author":"Frishman","year":"2009","journal-title":"ynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201411000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:01:51Z","timestamp":1779980511000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201411000-00006"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000515","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}